Trial Now Recruiting: National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases (NCT06491615)
WHY IT MATTERS
If you have one of the listed inherited eye diseases (like Best disease, aniridia, or albinism), joining this registry could help researchers discover new treatments while contributing your genetic data to advance understanding of your specific condition.
The eyeGENE program is a national registry that collects genetic information, eye imaging, and DNA samples from people with inherited eye diseases. Researchers use this information to understand what causes these diseases and develop better treatments. The program is now expanding and looking for 1,000 more participants with various rare inherited eye conditions.
NCT ID: NCT06491615 Status: RECRUITING Conditions: Inherited Ophthalmic Diseases, Hypopigmentation Disorder, Corneal Dystrophy, Blue-cone Monochromacy, Best Disease, Aniridia, Albinism Enrollment: 1000 Sponsor: National Eye Institute (NEI) Summary: Background: The eyeGENE (Registered Trademark) program is a research resource for inherited eye conditions which includes genotypic and phenotypic data, imaging, and a corresponding biobank of DNA samples from people with a variety of eye diseases. Since 2007 this registry has been helping researchers learn more about the genetic sources for many inherited eye diseases. These findings helped them create better treatments. Now researchers want to expand eyeGENE (Registered Trademark) to include
YOU CAN ACT ON THIS
If you have one of the listed eye conditions, visit clinicaltrials.gov (NCT06491615) or contact the National Eye Institute to learn how to enroll in this actively recruiting study.